Canopy Growth (CGC) Goodwill & Intangibles (2017 - 2026)
Canopy Growth (CGC) posted Goodwill & Intangibles of $213.7 million for Q1 2026, up 140.95% sequentially from $88.7 million in Q4 2025, and up 130.15% YoY from $92.9 million in Q1 2025.
Canopy Growth (CGC) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Canopy Growth has reported Goodwill & Intangibles for 10 years, with the latest figure at $213.7 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 130.15% year-over-year to $213.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $213.7 million (up 130.15% YoY) and the FY2026 annual result came in at $213.7 million, up 130.15% from the prior year.
- Goodwill & Intangibles grew to $213.7 million in Q1 2026 per CGC's latest filing, from $88.7 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $1.6 billion in Q1 2022 and troughed at $72.4 million in Q2 2025.
- A 5-year average of $251.9 million and a median of $173.5 million in 2023 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2023 and 2026: Goodwill & Intangibles tumbled 90.27% in 2023, then jumped 130.15% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $269.8 million in 2022, then declined by 22.17% to $210.0 million in 2023, then plunged by 54.37% to $95.8 million in 2024, then declined by 7.45% to $88.7 million in 2025, then soared by 140.95% to $213.7 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $213.7 million, $88.7 million, and $94.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Canopy Growth | 439.15 Mn | 192.14 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 252.73 Mn |
| Mar 31, 2026 | 213.71 Mn |
| Dec 31, 2025 | 88.70 Mn |
| Sep 30, 2025 | 94.02 Mn |
| Jun 30, 2025 | 72.40 Mn |
| Mar 31, 2025 | 92.86 Mn |
| Dec 31, 2024 | 95.84 Mn |
| Sep 30, 2024 | 180.87 Mn |
| Jun 30, 2024 | 83.09 Mn |
| Mar 31, 2024 | 109.31 Mn |
| Dec 31, 2023 | 210.02 Mn |
| Sep 30, 2023 | 173.52 Mn |
| Jun 30, 2023 | 199.01 Mn |
| Mar 31, 2023 | 160.10 Mn |
| Dec 31, 2022 | 269.85 Mn |
| Sep 30, 2022 | 270.83 Mn |
| Jun 30, 2022 | 322.66 Mn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 1.76 Bn |
| Sep 30, 2021 | 1.78 Bn |